2025年,Beark Point资本公司在iShares生物技术电子信托基金上投资了320K美元,而高级信托基金则将其持有量削减了45.1%。 In Q1 2025, Bearing Point Capital invested $320K in the iShares Biotechnology ETF, while Advantage Trust cut its holdings by 45.1%.

在2025年第一季度,Beark Point资本有限公司在iShares生物技术电子信托基金(IBB)投资了大约320 000美元,购买了2 500股股票。 In the first quarter of 2025, Bearing Point Capital LLC invested approximately $320,000 in the iShares Biotechnology ETF (IBB), purchasing 2,500 shares. 同时,优惠信托公司将其IBB持有的股份减少了45.1%,出售了4 220股。 Meanwhile, Advantage Trust Co reduced its IBB holdings by 45.1%, selling 4,220 shares. 跟踪NASDAQ生物技术指数的ETF在第一个季度增加了3.4%,12个月的价格从107.43美元到150.57美元不等。 The ETF, which tracks the NASDAQ Biotechnology Index, saw a 3.4% increase in the first quarter, with a 12-month price range from $107.43 to $150.57.